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MEDICAL BOARD OF CALIFORNIA 
Executive Director, Kimberly Kirchmeyer: (916) 263-2389 ♦ License Verification, General 
Licensing, Application and Complaint Information (Toll-Free): 1-800-633-2322 ♦ Website: 
www.mbc.ca.gov  
 
Protection of the public shall be the highest priority for the Medical Board of 
California in exercising its licensing, regulatory, and disciplinary functions. 
Whenever the protection of the public is inconsistent with other interests 
sought to be promoted, the protection of the public shall be paramount. 
 
— Business and Professions Code § 2000.1 
 
he Medical Board of California (MBC) is a consumer protection agency within 
the state Department of Consumer Affairs (DCA). The 15-member Board 
consists of eight physicians and seven public members. MBC members are 
appointed by the Governor (eight physicians and five public members), the Speaker of the 
Assembly (one public member), and the Senate Rules Committee (one public member). Members 
serve a four-year term and are eligible for reappointment to a second term. Several standing 
committees and ad hoc task forces assist the Board.  
The primary purpose of MBC is to protect consumers from incompetent, grossly negligent, 
unlicensed, impaired, or unethical practitioners by responding to complaints from the public and 
reports from health care facilities and other mandated reporters. MBC reviews the quality of 
medical practice carried out by physicians and surgeons, and enforces the disciplinary, 
administrative, criminal, and civil provisions of the Medical Practice Act, Business and 
Professions Code section 2000 et seq. MBC also provides public record information about 
physicians to the public via its website and individual requests, and educates healing arts licensees 
and the public on health quality issues. The Board’s regulations are codified in Division 13, Title 
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MBC is responsible for ensuring that all physicians licensed in California have adequate 
medical education and training. In this regard, the Board issues regular and probationary licenses 
and certificates under its jurisdiction, administers a continuing medical education program, and 
administers physician and surgeon examinations to some license applicants. MBC also oversees 
the regulation of licensed midwives; polysomnographic technologists, technicians, and trainees; 
research psychoanalysts; and medical assistants.  
On December 13, 2018, then-Governor Jerry Brown appointed Susan F. Friedman and 
Laurie Rose Lubiano, J.D., to MBC. Ms. Friedman was a career network news producer for NBC 
News, is Vice-Chair of the Los Angeles County Commission on Mental Health, a founding board 
member of The Alliance for Children’s Rights, and former President of the Los Angeles County 
Commission on Children and Families. Ms. Lubiano is intellectual property counsel with The 
Climate Corporation and served as a member of the Daly City Planning Commission.  
At this writing, the Board has two vacancies—both physician members—which must be 
filled by Governor Gavin Newsom.  
MAJOR PROJECTS 
Petition for Rulemaking: Approved Medical Assistant 
Certifying Organizations 
On November 9, 2018, Ellison Wilson Advocacy, LLC, on behalf of the National Health 
Career Association (“Petitioners”), submitted a petition for rulemaking to MBC pursuant to 
Government Code section 11340.6. Petitioners requested that MBC amend section 1366.31, Title 
16 of the CCR to revise the Board’s criteria for approving organizations that certify medical 
assistants pursuant to section 1366.31(c)(1). Medical assistants are generally not legally required 
to receive certification in order to perform their technical supportive services. However, medical 
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assistants must receive certification from an MBC-approved certifying organization if they will be 
training other medical assistants. Current section 1366.31 requires that approved medical assistant 
certifying organizations be non-profit and tax-exempt organizations. Petitioners requested that 
MBC amend the section to strike this requirement, thus making for-profit medical assistant 
certifying organizations eligible for MBC approval. 
As reported by MBC staff, according to the original rulemaking file, the purpose of the 
regulation was to avoid approving certifying agencies motivated solely by profits and not by 
training quality and patient safety. Petitioners contend that many for-profit certifying organizations 
create non-profit extensions of their existing organizations solely to satisfy the requirement of 
section 1366.31, and that being non-profit is, thus, not indicative of the quality of a certifying 
organization. In addition to requesting the striking of the non-profit requirement, Petitioners also 
suggest that MBC consider requiring that certifying organizations receive accreditation by the 
National Commission for Certifying Agencies (“NCCA”) before receiving Board approval.  
At its February 1, 2019 meeting, MBC voted unanimously to approve the petition for 
rulemaking in concept, directed staff to draft proposed language for an amended version of section 
1366.31 for discussion at a later meeting, and directed staff to study how striking the non-profit 
requirement will affect matters like accreditation quality, patient safety, and cost to consumers.  
Approved Postgraduate Training 
On January 25, 2019, MBC published notice of its intent to amend section 1321, Title 16 
of the CCR to clarify the geographic and accreditation requirements for MBC-approved and state-
mandated postgraduate training courses. According to the initial statement of reasons, the proposed 
modification is the Board’s effort to make the provisions of section 1321 “consistent with current 
accreditation practices meeting California requirements for approved postgraduate training in the 
 
44 
California Regulatory Law Reporter ♦ Volume 24, No. 2 (Spring 2019) ♦ 
Covers October 16, 2018 – April 15, 2019 
United States and Canada.” The initial statement of reasons further states that the modification to 
section 1321 is meant to clarify that only postgraduate training programs located in the United 
States and its territories or Canada are MBC-approved in California. The public comment period 
ended on March 11, 2019, and culminated with a Public Hearing on the matter in Sacramento on 
that date.  
Vertical Enforcement Program Ends 
At its October 18, 2018 meeting, MBC staff discussed the upcoming repeal of the vertical 
enforcement (VE) program, effective January 1, 2019. [23:2 CRLR 46–48] As explained by MBC 
Executive Director Kimberly Kirchmeyer, the legislature’s failure to extend VE’s sunset date 
means MBC will return to using the investigatory process currently utilized by other DCA boards. 
This older “hand-off” model excludes the California Attorney General’s Office from many steps 
of the investigatory process, and requires the Health Quality Investigation Unit (HQIU) to make 
case disposition recommendations directly to the Board and not, as under VE, to the Attorney 
General’s Office. In the event the Board finds that a case warrants disciplinary action, a Deputy 
Attorney General (DAG) reviews the case to ensure that there is sufficient evidence justifying the 
filing of an accusation. Ms. Kirchmeyer stated that it is the Board’s intention to work 
collaboratively with HQIU and the Attorney General’s Office to ensure a smooth transition away 
from VE and to track changes in investigation and enforcement timelines post-transition.  
VE was instituted in 2006 as a result of the passage of MBC’s 2005 sunset bill, SB 231 
(Figueroa) (Chapter 674, Statutes of 2005), and resulted from an extensive audit of MBC’s 
enforcement program by the independent Medical Board Enforcement Program Monitor. The 
Monitor recommended not only the use of VE but also the transfer of MBC’s investigators from 
the Board to HQE, so that the two sets of professionals could work at the same agency; the transfer 
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proposal was rejected by the Schwarzenegger administration but the VE recommendation was 
included in SB 231. From its inception, VE has been controversial at MBC, whose staff has urged 
on several occasions that VE be limited to certain kinds of cases. The Center for Public Interest 
Law (CPIL), whose Administrative Director Julianne D’Angelo Fellmeth served as MBC 
Enforcement Program Monitor from 2003–2005, opposed the repeal of VE and testified at the 
October 18, 2018 meeting. For a full description of the chronology of events leading to VE’s 
sunset. [see 23:1 CRLR 36–40] VE formally sunset on January 1, 2019.  
MBC Rejects American Board of Cosmetic Surgery’s 
Application for Specialty Board Equivalency 
Recognition  
At its October 18, 2018 meeting, the Board considered the American Board of Cosmetic 
Surgery’s (ABCS) application for MBC recognition as a specialty board, which would allow 
ABCS members to advertise themselves as “board-certified” under Business and Professions Code 
section 651. In order to receive MBC approval for recognition as a specialty board, ABCS must 
demonstrate compliance with the laws and regulations and show that they are equivalent to 
member boards of the American Board of Medical Specialties (ABMS). At the meeting, an expert, 
retained by MBC to opine on the merits of ABCS’s application for specialty board equivalency 
recognition in California, recommended that the Board reject ABCS’s application, noting 
deficiencies with ABCS’s training policies and procedures. As noted by MBC Executive Director 
Kirchmeyer at that meeting, SB 798 (Hill) (Chapter 775, Statutes of 2017) strips MBC of its 
authority to deem specialty board equivalency effective January 1, 2019. After a lengthy discussion 
between MBC staff, Board members, the expert, and various interested parties and individuals, the 
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Board voted to gather more information and have an interim meeting before December 31, 2018, 
to make a final determination on ABCS’s application for equivalency recognition.  
At its December 18, 2018 meeting, MBC once again took up the issue of ABCS’s 
application for equivalency recognition. After lengthy debate and discussion between MBC staff, 
Board members, the expert, and various interested parties and individuals, MBC followed the 
expert’s recommendation and voted unanimously to reject ABCS’s application for equivalency 
recognition. 
Revisions to Questions Regarding Impairment on 
Applications for Licensure and Registration 
At its January 31, 2019 meeting, the Board considered two sets of revised licensure 
application questions. MBC’s licensure and registration applications currently require applicants 
to disclose whether they have, at any time, received a diagnosis for an emotional, mental, 
behavioral, addictive, neurological, or other physical disorder or condition that impairs their ability 
to practice medicine safely. In April 2018, the Federation of State Medical Boards (FSMB), after 
researching physician wellness and burnout, published recommendations for state medical boards 
regarding revisions to certain questions on applications for licensure and registration. Specifically, 
FSMB recommended that state medical boards consider revising or excluding application 
questions concerning an applicant’s mental health or substance abuse histories if those questions 
are worded in such a way as to discourage physicians seeking treatment from disclosing pertinent 
information. According to FSMB, application questions should not give the appearance to 
physicians seeking treatment that disclosing information is meant to be punitive instead of 
beneficial. To ensure compliance with the Americans with Disabilities Act (ADA), FSMB also 
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recommended that application questions focus on an applicant’s ongoing impairments and not on 
other previous impairments, illnesses, diagnoses, or treatment.  
At the January meeting, staff presented the Board with two alternatives, taking FSMB’s 
recommendations as well as additional suggestions from interested parties into consideration. 
After numerous Board members expressed concern about the scope and purpose of the draft 
revised application questions, the Board unanimously passed a motion to table the conversation, 
refer the matter to a committee to be appointed by the President in relation to physician wellness, 
and to report back to the Board for further action. It was noted by several Board members that 
there is no state mandate or legal action requiring these changes at this time. The Board is expected 
to revisit the draft application at its May meeting. 
Presentation and Update on the Health Professions 
Education Foundation Program 
At MBC’s October 18, 2018 meeting, the Executive Director of the Health Professionals 
Education Foundation (HPEF), Norlyn Asprec, provided an informational overview of the 
program and its history to the Board. The HPEF seeks to improve healthcare access in underserved 
regions of California “by providing scholarships and loan repayment programs to health 
professional students and graduates who are dedicated to providing direct patient care in those 
areas.” The Steven M. Thompson Physicians Corps Loan Repayment Program, perhaps the most 
notable of the HPEF’s programs, is designed to “increase the number of culturally and 
linguistically competent physicians who are practicing in medically underserved areas of 
California,” and is funded in part by a $25/licensee MBC licensing fee. The HPEF is currently 
developing a survey to gauge the physician retention levels in designated underserved areas after 
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applicants complete their loan repayment programs or receive their scholarships. The HPEF plans 
to conduct the survey by the end of the year.  
MBC Holds Patient Advocate Meeting 
On February 1, 2019, MBC held a Patient Advocate Interested Parties meeting. At the 
meeting, MBC provided an overview of its enforcement process for licensees, a summary of the 
various types of enforcement documents and when and how the public may access those 
documents, and presented highlights from its 2017–2018 Annual Report. An open discussion with 
patient advocates and other interested parties followed these presentations.  
LEGISLATION 
AB 387 (Gabriel), as introduced February 5, 2019, would add section 2051.1 to the Business 
and Professions Code to require physicians and surgeons to advise patients as to the purpose of a 
prescribed drug or device upon prescription of the drug or device, and permit patients to opt out 
of having the purpose of a prescribed drug or device included on the prescription label. According 
to the author, “[a]dverse drug events (ADEs) due to medications with similar names are common 
and estimated to be responsible for thousands of deaths and millions of dollars in costs every year.” 
This bill intends to make it easier for consumers to recognize appropriate medication. [A. Appr] 
SB 786 (Senate Committee on Business, Professions, and Economic Development) , as 
amended April 11, 2019, would repeal Article 11 (commencing with section 2200) of Chapter 5 
of Division 2 of the Business and Professions Code. Existing law authorizes MBC to, in specified 
circumstances, make loans repayable to the Contingent Fund of the MBC at a prescribed interest 
rate to medical students. Existing law also authorizes MBC to grant loans repayable to the 
Contingent Fund of the MBC to certain licensees who agree to establish medical practices in areas 
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underserved by primary care services. SB 786 would repeal these provisions in their entirety 
because the programs are no longer operational. According to the author, this is a technical clean-
up bill that should be non-controversial. [S. BP&ED]  
AB 241 (Kamlager-Dove), as amended April 4, 2019, would amend section 2190.1 of the 
Business and Professions Code to require, on and after January 1, 2022, that all continuing 
education courses for physician and surgeons contain curriculum that includes the understanding 
of implicit bias and the promotion of bias-reducing strategies to address how unintended biases in 
decision-making may contribute to health care disparities. Among other things, the legislature 
found that implicit bias contributes to the unequal treatment of patients based on immutable 
characteristics including race, ethnicity, gender identity, and sexual orientation. Further, unequal 
treatment of certain patients by licensees leads to health disparities in these vulnerable populations, 
even when controlling for other factors. Amended section 2190.1 would elaborate on these and 
other findings and restate the legislature’s intent for providing MBC and other licensees with the 
education, tools, and resources for identifying and reducing implicit bias in the treatment and care 
of patients. [A. B&P] 
AB 845 (Maienschein), as amended April 1, 2019, would add section 2196.9 to the 
Business and Professions Code to require MBC to consider including a course in maternal mental 
health when determining its continuing education requirements for doctors and to make periodic 
updates to any course curricula with new research findings on maternal mental health. According 
to the author, maternal mental health disorders are the most common complication of giving birth, 
and in light of prevalence (affecting one in five mothers in California), health care providers need 
training to identify and treat them appropriately. Existing law requires providers to screen pregnant 
and postpartum women for maternal mental health conditions as of July 1, 2019. Existing law also 
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requires specified hospitals to develop and implement programs relating to postpartum depression 
and other maternal mental health conditions. [A. Appr] 
SB 425 (Hill), as amended April 11, 2019, would amend sections 2221 and 2234 of the 
Business and Professions Code to require MBC to disclose probationary certificates and the 
statement of issues to an interested member of the public and to post these documents on MBC’s 
website for ten years from the date of issuance. Also, amended section 2234 would remove the 
condition that failure to attend and participate in an investigation-related interview with MBC, 
without good cause, be repeated before rising to the level of “unprofessional conduct” 
disciplinable by MBC. SB 425 arises out of a hearing held in 2018 by the Senate Committee on 
Business, Professions and Economic Development (Sexual Misconduct Reporting in the Medical 
Profession: Missed Opportunities to Protect Patients), that explored whether licensed health 
professionals who fail to meet established standards are discovered, reviewed and disciplined, if 
necessary, in a timely manner. The Board supports three provisions in the bill related to MBC 
enforcement, which it believes will help to prevent delays in the Board’s enforcement process, and 
will increase transparency by providing access to information that is public, but not available on 
MBC’s website after a probationary period is complete. MBC’s position does not reference 
provisions related to receiving reports about sexual abuse and misconduct allegations involving a 
MBC licensee, nor does MBC have a position on provisions related to interim suspension orders. 
[S. Jud]  
AB 1264 (Petrie-Norris), as amended March 26, 2019, is an urgency statute that would 
amend section 2242.2 of the Business and Professions Code to clarify that, for purposes of this 
section, “appropriate prior examination” is not meant to require real-time interaction between the 
 
51 
California Regulatory Law Reporter ♦ Volume 24, No. 2 (Spring 2019) ♦ 
Covers October 16, 2018 – April 15, 2019 
patient and the licensee. Instead the section allows the use of a self-screening tool that allows 
hormonal contraceptives to be prescribed by a licensed prescriber. [A. Appr] 
SB 377 (McGuire), as amended April 11, 2019, would amend sections 369.5 and 739.5 of 
the Welfare and Institutions Code to, upon approval by a juvenile court judicial officer of a request 
for authorization for the administration of psychotropic medication to a juvenile patient, require 
the officer to authorize MBC to review the patient’s medical record. Amended section 369.5 would 
limit review of the juvenile patient’s medical record to the diagnosis for the authorized prescription 
of psychotropic medication, so MBC can determine whether excessive prescribing inconsistent 
with the standard of care is occurring. Existing law requires MBC to review certain data provided 
by the State Department of Health Care Services and the State Department of Social Services 
concerning Medi-Cal providers and their prescribing patterns regarding psychotropic medications 
and related services for foster youth, and to conduct an investigation if any potential legal 
violations or excessive prescribing inconsistent with the established standard of care exists. [S. 
Jud] 
AB 1030 (Calderon and Petrie-Norris), as amended March 26, 2019, would amend 
section 2249, and add section 2248.9 to the Business and Professions Code to require MBC, in 
coordination with the American College of Obstetricians and Gynecologists and other groups, to 
develop an informational pamphlet for patients undergoing gynecological exams by July 1, 2020. 
Allegedly, proposed in response to the allegations of repeated misconduct by a USC gynecologist, 
the new sections would require the pamphlet to contain certain information, such as what pelvic 
exams and pap smears are, how doctors perform them, and patient privacy expectations. MBC 
would also have to make the pamphlet available online or in print to licensees that perform 
gynecological examinations.  [A. Appr] 
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SB 201 (Wiener), as amended March 25, 2019, would add section 2295 to the Business 
and Professions Code to prohibit a doctor from performing any treatment or intervention, other 
than one which is medically necessary, on the sex characteristics of an intersex minor, and if that 
treatment or intervention may be deferred until the intersex minor can provide informed consent. 
New section 2295 would authorize MBC to develop and adopt medical guidelines to implement 
these provisions and take necessary disciplinary action when violations occur. [S. BP&ED] 
AB 149 (Cooper), as amended February 19, 2019, amends sections 11162.1 and 11164 of, 
and adds section 11162.2 to, the Health and Safety Code to clarify that prescriptions for controlled 
substances written on otherwise valid prescription forms before January 1, 2019, that do not yet 
comply with the serialization requirement of existing law, are valid and may be filled, 
compounded, or dispensed until January 1, 2021. Also under this bill, the Department of Justice 
may, if supply and demand so require, extend the period during which prescriptions written on 
noncompliant forms remain valid for up to six additional months. MBC voted to support AB 149. 
Governor Gavin Newsom signed AB 149, an urgency statute, on March 11, 2019 (Chapter 
4, Statutes of 2019), which took effect immediately.  
AB 544 (Brough), as amended March 21, 2019, would amend sections 2427 and 2456.3 
of the Business and Professions Code to limit the maximum fee for the renewal of an inactive 
license to no more than fifty percent of the renewal fee for an active license. The bill would also 
prohibit MBC from requiring payment of unpaid renewal fees as a condition of reinstating an 
expired license. According to the author, the bill is necessary because often the fee paid for the 
renewal of an inactive license is the same as the full fee paid for renewal by active license holders. 
Also, for certain licenses that have expired, all accrued fees must be paid as a condition of 
reinstatement of the license, which can be a barrier to re-entry to the profession. [A. B&P] 
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AB 370 (Voepel), as amended March 12, 2019, would add Article 16 (commencing with 
section 2380) to Chapter 5 of Division 2 of the Business and Professions Code to limit the amount 
that doctors may charge patients for filling out certain medical and related forms to a reasonable 
fee based on the actual time and cost for filling out the form. Additionally, AB 370 provides that 
a violation of its provisions is not a crime. [A. Health] 
LITIGATION 
Grafilo v. Cohanshohet, Case No. BS169143 (Super. Ct. Los Angeles). Based on an 
anonymous complaint filed against Dr. Cohanshohet, MBC initiated an investigation of this doctor. 
MBC’s medical expert concluded that five patients may have received excessive amounts of 
opioids as compared to the recommended dosage. MBC’s expert explained the five patients’ 
medical records were necessary to determine whether Dr. Cohanshohet performed an examination 
and screening of those patients, received informed consent, regularly assessed the efficacy and 
effects of the treatment regimen, and monitored those patients.  
Four of the five patients submitted declarations objecting to the petition. Dr. Cohanshohet 
also opposed the petition, asserting the Board lacked good cause to justify the intrusion into his 
patients’ privacy rights. Dr. Cohanshohet asserted in a declaration that he completed hundreds of 
hours of post-graduate training in pain management and palliative care and that some of his 
patients suffer from pain associated with acute injuries while others seek active cancer treatment, 
palliative care, or end-of-life care. Dr. Cohanshohet’s medical expert challenged MBC’s expert’s 
conclusions and found there was no reason to suspect Dr. Cohanshohet failed to perform a proper 
examination, obtain informed consent, or review the risks and benefits of higher dosage opioid 
therapy with the patient.  
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The lower court granted the petition and ordered Dr. Cohanshohet to produce the requested 
records. The doctor appealed. Dr. Cohanshohet contended the state’s interest in his patients’ 
medical records is insufficient to overcome their right to privacy, and he argued that MBC lacks 
authority to issue subpoenas for records of noncomplaining patients. The appellate court reversed 
the order, finding the state failed to demonstrate good cause to obtain the patients’ records because 
the records were not material or relevant to the investigation. The appellate court also awarded the 
doctor his costs to defend the petition. Id. at 18. 
Grafilo v. Wolfsohn, Case No. BS171234 (Super. Ct. Los Angeles). In a second recent 
case involving the standard of good cause for MBC to subpoena patient records in the scope of an 
investigation of a doctor, the appellate court again found that MBC did not show good cause in the 
lower court proceeding. In this case, also involving a pain management doctor and a subpoena for 
five patients’ medical records who challenged the order based on their right to privacy, the 
appellate court cited to Grafilo v. Cohanshohet in reversing the lower court’s ruling. The appellate 
court found that “[t]he defects in the evidence supporting the subpoenas in Cohanshohet are 
present here and there are no additional facts that add substantial weight in favor of the subpoena.” 
Id. at 16. The appellate court found that MBC offered no evidence as to how many patients Dr. 
Wolfsohn treats, the percentage of his patients the five patients comprised, how often similarly-
situated pain management specialists might prescribe the drugs that Dr. Wolfsohn prescribed, or 
the likelihood that Dr. Wolfsohn properly issued the prescriptions. Id.  
RECENT MEETINGS 
At its October 18, 2018 meeting, Executive Director Kirchmeyer explained that the 
Board’s Executive Committee draws its membership from the Board’s officers, its most recent 
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past President, and the Chair of each standing committee. Depending on which Board members 
occupy each of these positions, the ratio of physician members to public members on the Executive 
Committee may be unacceptably unbalanced. In response, MBC voted to change the Executive 
Committee’s makeup to the Board’s officers (its most recent past President, and two to three 
additional members appointed by the Board President) to allow for balancing of physician and 
public members.  
At its October 18, 2018 meeting, MBC President Pines also appointed Dr. Krauss and Dr. 
Hawkins to the Board’s newly-formed and newly-renamed Stem Cell and Regenerative Therapy 
Task Force. At that meeting, President Pines also appointed Dr. GnanaDev and Dr. Yip to the 
Board’s newly-formed Compounding Task Force.  
